Insider Transactions in Q1 2025 at Pfizer Inc (PFE)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 23
2025
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
390
-4.14%
|
$10,140
$26.3 P/Share
|
|
Feb 23
2025
|
Christoffel Boshoff President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-0.44%
|
$17,212
$26.3 P/Share
|
|
Feb 22
2025
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
8,188
-23.76%
|
$212,888
$26.19 P/Share
|
|
Feb 22
2025
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
8,741
+33.18%
|
$262,230
$30.17 P/Share
|
|
Feb 22
2025
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,422
-5.98%
|
$270,972
$26.19 P/Share
|
|
Feb 22
2025
|
Michael Mc Dermott Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
11,125
+11.26%
|
$333,750
$30.17 P/Share
|
|
Feb 22
2025
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
79,899
-17.4%
|
$2,077,374
$26.19 P/Share
|
|
Feb 22
2025
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
85,824
+26.94%
|
$2,574,720
$30.17 P/Share
|
|
Feb 22
2025
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
221,515
-19.71%
|
$5,759,390
$26.19 P/Share
|
|
Feb 22
2025
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
238,399
+29.47%
|
$7,151,970
$30.17 P/Share
|
|
Feb 22
2025
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
59,500
-13.37%
|
$1,547,000
$26.19 P/Share
|
|
Feb 22
2025
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
63,573
+22.02%
|
$1,907,190
$30.17 P/Share
|
|
Feb 22
2025
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
11,911
-16.29%
|
$309,686
$26.19 P/Share
|
|
Feb 22
2025
|
Payal Sahni Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
12,714
+25.52%
|
$381,420
$30.17 P/Share
|
|
Feb 22
2025
|
Christoffel Boshoff President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
8,138
-2.56%
|
$211,588
$26.19 P/Share
|
|
Feb 22
2025
|
Christoffel Boshoff President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,741
+5.21%
|
$262,230
$30.17 P/Share
|
|
Feb 13
2025
|
Ronald E Blaylock Director |
BUY
Open market or private purchase
|
Direct |
19,457
+41.25%
|
$486,425
$25.65 P/Share
|
|
Jan 31
2025
|
Christoffel Boshoff President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
12,038
-7.41%
|
$312,988
$26.52 P/Share
|